Skip to main content

Table 1 Characteristics of the studies included in the meta-analysis

From: Radiofrequency ablation versus hepatic resection for the treatment of early-stage hepatocellular carcinoma meeting Milan criteria: a systematic review and meta-analysis

Study

Research period

RFA (n)

HR (n)

Trial type

Tumor diameter (cm)

Grade

Chen et al. 2006 [15]

1999–2004

71

90

RCT

≤5

A

Cho et al. 2005 [25]

2000–2002

99

61

NRCT

≤5

B

Guglielmi et al. 2008 [26]

1996–2006

109

91

NRCT

≤3

B

Guo et al. 2013 [27]

2002–2007

94

102

NRCT

≤5

B

Hasegawa et al. 2008 [28]

2000–2003

3022

2857

NRCT

≤3

B

Hiraoka et al. 2008 [29]

2000–2007

105

59

NRCT

3–5

B

Hong et al. 2005 [19]

2000–2003

55

55

NRCT

≤4

B

Huang et al. 2011 [14]

2000–2005

413

648

NRCT

≤3

B

Lu et al. 2006 [30]

2002–2005

51

54

RCT

≤3

A

Lupo et al. 2007 [24]

2003–2004

42

60

NRCT

3–5

B

Ueno et al. 2009 [31]

2000–2005

155

123

NRCT

≤5

B

Vivarelli et al. 2004 [20]

1998–2005

79

79

NRCT

≤5

B

  1. HR hepatic resection, NRCT nonrandomized controlled trial, RCT randomized controlled trial, RFA radiofrequency ablation.